Therapeutic Solutions International, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OTC.Pink
Form 4: Therapeutic Solutions International CEO Timothy Dixon Reports Significant Share Transactions
CEO Timothy Dixon reports acquiring and disposing of shares in Therapeutic Solutions International, Inc.
OTC.Pink
Director Thomas Ichim reports acquisition and disposal of Therapeutic Solutions International (TSOI) common stock.
OTC.Pink
Timothy G. Dixon, President & CEO of Therapeutic Solutions International, acquires 13,333,333 shares of common stock at $0.0006 per share.
OTC.Pink
Thomas Ichim, a director of Therapeutic Solutions International, acquired 10,000,000 shares of common stock at a price of $0.0006 per share on July 11, 2024.
OTC.Pink
Timothy G. Dixon, President & CEO of Therapeutic Solutions International, acquires 20,000,000 shares of common stock at $0.0006 per share.
OTC.Pink
Thomas Ichim, a director of Therapeutic Solutions International, acquired 10 million shares of common stock at $0.0008 per share and disposed of 187 million shares on July 8, 2024.
OTC.Pink
Timothy G. Dixon, President & CEO of Therapeutic Solutions International, acquired 25 million shares of common stock at a price of $0.0008 per share on July 8, 2024.
OTC.Pink
Director Thomas Ichim reports acquiring 10,000,000 shares of Therapeutic Solutions International at $0.0008 per share and disposing of 177,000,000 shares.
OTC.Pink
Timothy G. Dixon, President & CEO of Therapeutic Solutions International, acquired 37.5 million shares of common stock at a price of $0.0008 per share on May 30, 2024.
OTC.Pink
Timothy G. Dixon, President & CEO of Therapeutic Solutions International, Inc., reports acquiring 42,857,142 shares of common stock at $0.0007 per share on April 18, 2024.
OTC.Pink
Thomas Ichim, a director of Therapeutic Solutions International, acquired 15,000,000 shares of common stock at a price of $0.0007 per share on April 18, 2024.